Pfizer, Inc. vs Insulet Corporation — Stock Comparison

PFE
Pfizer, Inc.
$26.33
▼ 1.39%
vs
PODD
Insulet Corporation
$175.04
▲ 1.68%
Q·Score Winner
Insulet Corporation
PODD7.8/10vs 6.5/10

Q·Score Breakdown

6.5
Neutral
Overall
7.8
Bullish
7.4
Quality
6.4
7
Health
7.9
5.6
Growth
8
6.7
Valuation
9.1
5.2
Sentiment
8.1
PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

PODD

Consensus analyst target of $326.35 is 86% above current price.

Analyst Consensus

HOLD
Target $29.00 (+10.2%)
27 analysts
BUY
Target $326.35 (+86.4%)
23 analysts

Fundamentals

PFE
PODD
19.4×
Trailing P/E
50.3×
9.4×
Forward P/E
21.7×
12.4%
Profit Margin
9.1%
75.8%
Gross Margin
71.6%
8.9%
ROE
18.1%
-1.2%
Revenue Growth
31.2%
Earnings Growth
3.9%
0.39
Beta
1.47
Price / Book
$149.8B
Market Cap
$12.1B
$22 – $29
52-Week Range
$158 – $355

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →